Healthcare and Life Science
Mitigating risk: A conversation with Biocair's Sarah Pentney
Sarah Pentney, Biocair’s Global Quality and Compliance Manager, discusses how to stay up-to-date on the regulatory landscape and what is involved in mitigating risk when shipping Active Pharmaceutical Ingredients (APIs) and finished drug products. ...
Biocair announces event to advise on building a resilient supply chain
Biocair is aiming to educate Contract Manufacturing Organisations (CMOs) and pharmaceutical sponsors on the value of lane risk assessments ahead of shipping Active Pharmaceutical Ingredients (APIs) and finished drug products globally. ...
Klebsiella pneumoniae vaccines - time to reprioritize
This month VacZine Analytics, a UK-based strategic research publisher exclusively focused on vaccines and infectious diseases, releases a brand-new global forecast of new Klebsiella pneumoniae vaccines. ...
International Day of Persons with Disabilities
International Day of Persons with Disabilities - an annual campaign aiming to join communities together to support people with disabilities and create a future for them where they experience equal opportunities and face no barriers in all aspects of their lives including employment. The...
Webcasting Plan B
“We pay you for when it goes wrong not for when it goes right” Roy Shepard executive producer explains why you need an experienced webcasting crew and always have a plan B. ...
South Africa expansion delivers growth opportunities for Biocair
Biocair has invested heavily in the expansion of its South Africa operation with the opening of two new offices. ...
Life-saving ambulance service marks birthday
A life-saving service for critically ill and injured hospital patients celebrates its first birthday today. ...
Cresset CEO’s end of year message 2022
As we near the end of another year, Dr Robert Scoffin, CEO of Cresset, reflects on the events of 2022 ...
ARU vision experts receive high-profile recognition
College of Optometrists bestows awards for ‘outstanding achievements’ in the field. ...
AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy
Acquisition provides access to next-generation T-cell receptor therapies with promising potential for targeting solid tumours. ...